Café

© 2026 Longbridge｜Terms of Service Privacy Policy

Gossamer Bio

GOSS

0.178313.74% ( -0.0284 )

Closed: Jul 30, 15:59:55 (EDT)

OverviewOverview OptionsOptions NewsNews PostsPosts FinancialsFinancials ForecastForecast ValuationValuation ShareholdersShareholders ProfileProfile

LongbridgeAI

Gossamer Bio jumps 10% in after-hours trading as Leerink upgrades to Outperform
US Stock Market Update·1 day ago, 04:32 PM
GOSS-13.74%
Gossamer Bio climbs 2% as Leerink upgrades to Outperform
US Stock Market Update·2 days ago, 12:50 PM
GOSS-13.74%
Gossamer Bio surges over 10% as Leerink upgrades to Outperform
US Stock Market Update·2 days ago, 09:10 AM
GOSS-13.74%
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
benzinga_article·2 days ago, 07:05 AM
ALT+2.05%OTLK+4.00%
This Honeywell Analyst Is No Longer Bearish; Here Are Top 5 Upgrades For Tuesday
benzinga_article·2 days ago, 06:33 AM
CIB+4.94%GOSS-13.74%
Top Biotech Gainers: GOSS To File Seralutinib NDA In Sep, OMER Gains On AZN's Loss, FBRX Acquired
rttnews·2 days ago, 10:34 PM
FBRX+0.59%TVGNW-7.37%
12 Health Care Stocks Moving In Monday's After-Market Session
benzinga_article·Jul 27 at 04:06 PM
RDHL-7.63%OPK-2.20%
Gossamer Bio | 8-K: FY2026 Q2 Revenue Misses Estimate at USD 0
Earnings Watch·Jul 27 at 03:03 PM
GOSS-13.74%
Gossamer Bio shares are trading higher after a pre‑NDA meeting and FDA minutes outlined a path to a September 2026 NDA filing for seralutinib in PAH. The company also regained global rights to the drug and won shareholder approval for a note exchange and reverse split to bolster its capital structure.
benzinga_article·Jul 27 at 01:16 PM
GOSS-13.74%
Gossamer Bio Restructures Debt, Secures Full Control of Lead Drug Candidate
benzinga_article·Jul 27 at 01:11 PM
GOSS-13.74%
12 Health Care Stocks Moving In Monday's Intraday Session
benzinga_article·Jul 27 at 12:06 PM
MPLT-6.59%PFSA+6.96%
Gossamer Bio shareholders approved convertible note exchange proposals at special meeting
PUBT·Jul 27 at 06:03 AM
GOSS-13.74%
Gossamer Bio shareholders approve charter amendment increasing authorized common shares to 4 billion
PUBT·Jul 15 at 05:26 AM
GOSS-13.74%
Gossamer Bio sets initial warrant exercise price at $0.34 per share
PUBT·Jul 1 at 08:01 AM
GOSS-13.74%